drugset / Trial / NCT03352323
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
NaSingle-groupOpen-labelTreatment
Summary
the study will measure the decrease in redness on the face of rosacea subjects
Timeline
- Start
- 2017-10-18
- Primary completion
- 2017-12-06
- Completion
- 2018-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxymetazoline | Other / unclassified | 1 % | Topical |